Back to RecallTracker
Health Canada Health products

Rivasa 81 mg EC tablet; Out of specification (salicylic acid impurity)

Issued June 6, 2025
Issue
The dosage of free salicylic acid impurity may be out of specification in the affected lot.
Hazard description
Product quality
What to do
Verify if your product is affected. Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns. Contact the recalling firm if you have any questions about the recall. Report any health product related side effects to Health Canada. Report any other health product safety complaints to Health Canada.
Product
Product name
RIVASA 81mg EC tablet
Reference
ID
RA-77564